Risk of Production, Sales and Business Partner Disruptions Due to COVID-19
First written in FY2020. 3 of 6 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
51 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In the event of a large-scale infectious disease outbreak, the group could be adversely affected by production stoppages at its production sites, business suspensions or lower operating efficiency at its operating sites, and business suspensions at its business partners.」
The company continues to identify the risk of production, operations, and business-partner disruptions caused by large-scale infectious diseases, generalized from a specific infectious disease. - FY2025RestatedAnnual report
「In the event of a large-scale infectious disease outbreak, the group could be adversely affected by production stoppages at its production sites, business suspensions or lower operating efficiency at its operating sites, and business suspensions at its business partners.」
The company continues to identify the risk of production, operations, and business-partner disruptions caused by large-scale infectious diseases, generalized from a specific infectious disease. - FY2023SoftenedAnnual report
「In the event of a large-scale infectious disease outbreak, the group could be adversely affected by production stoppages at its production sites, business suspensions or lower operating efficiency at its operating sites, and business suspensions at its business partners.」
The description has changed from one specifying COVID-19 to a general risk description referring to “large-scale infectious diseases.” - FY2021RestatedAnnual report
「The spread of COVID-19 could adversely affect the group through production stoppages at its production sites, business suspensions or lower operating efficiency at its operating sites, and business suspensions at its business partners.」
The company continues to disclose the risk of the impact of COVID-19 on production sites, operating sites, and business partners. - FY2021-Q1MaterialisedAnnual report
「Due to the food service industry’s restraint on advertising as a result of the impact of the novel coronavirus, revenue was ¥199 million, down 19.4% year on year.」
The impact of the novel coronavirus emerged as restraint on advertising by the food service industry, leading to a decline in revenue in the publishing and advertising business. - FY2020First statedAnnual report
「The spread of pneumonia caused by the novel coronavirus could adversely affect the group through production stoppages at its production sites, business suspensions or lower operating efficiency at its operating sites, and business suspensions at its business partners.」
For the first time, the company separately identified as a risk the possibility that the spread of the novel coronavirus could result in stoppages or lower operating efficiency at production sites, operating sites, and business partners, adversely affecting business performance.